$1.30
00.00%
Last update: 7:09 AM
15 minutes delayed
Gain Therapeutics
GANXNASDAQ
Gain Therapeutics (GANX) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestGain Therapeutics (NASDAQ:GANX) Stock Quotes, Forecast and News Summary
Gain Therapeutics Stock (NASDAQ: GANX) stock price, news, charts, stock research, profile.
| Open | $1.27 |
| Close | - |
| Volume / Avg. | 155.86K / 216.06K |
| Day Range | 1.26 - 1.30 |
| 52 Wk Range | 1.20 - 5.33 |
| Market Cap | $32.72M |
| P/E Ratio | - |
| Dividend Yield | - |
| Quote.Metrics.exchange | NASDAQ |
| RSI | 25 |
| Short Interest | 0.34% |
| Days to Cover | 1 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Gain Therapeutics (GANX) stock?
You can purchase shares of Gain Therapeutics (NASDAQ:GANX) through any online brokerage.
Who are Gain Therapeutics (GANX) competitors?
Other companies in Gain Therapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), Fortress Biotech (NASDAQ:FBIO), Estrella Immunopharma (NASDAQ:ESLA), Acurx Pharmaceuticals (NASDAQ:ACXP) and OncoCyte (NASDAQ:OCX).
What is the target price for Gain Therapeutics (GANX) stock?
There is no analysis for Gain Therapeutics.
What is the forecast for Gain Therapeutics (GANX) stock?
Gain Therapeutics has a consensus price target of $8.17.
Current stock price for Gain Therapeutics (GANX)?
The stock price for Gain Therapeutics (NASDAQ: GANX) is $1.26 last updated Today at June 26, 2024 at 2:11 PM EDT.
Does Gain Therapeutics (GANX) pay a dividend?
There are no upcoming dividends for Gain Therapeutics.
When is Gain Therapeutics (NASDAQ:GANX) reporting earnings?
Gain Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.
Is Gain Therapeutics (GANX) going to split?
There is no upcoming split for Gain Therapeutics.
What sector and industry does Gain Therapeutics (GANX) operate in?
Gain Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.